Navigation Links
Endo Reports First Quarter Financial Results And Announces Return To Steady Supply Of OPANA® ER And Voltaren® Gel
Date:5/1/2012

CHADDS FORD, Pa., May 1, 2012 /PRNewswire/ --

  • Total quarterly revenues of $691 million, increased 23 percent versus prior year; Driven by full quarter addition of AMS as well as Qualitest revenue growth of 8 percent. 
  • Adjusted diluted EPS of $0.87, aligned with prior guidance of below $0.90.
  • Reported quarterly diluted loss per share of $0.75 versus earnings per share of $0.46 for prior year.
  • Management expects return to year-over-year adjusted diluted earnings growth for remainder of 2012.
  • OPANA ER and Voltaren Gel now in steady supply;  Resolving temporary supply disruption announced in early January. 
  • Endo (Nasdaq: ENDP) today reported financial results for the first quarter of 2012.

    Total revenues during the first quarter of 2012 increased 23 percent to $691 million, compared with $560 million in the same quarter of 2011, reflecting organic growth and the acquisition of AMS.  Endo incurred a net loss for the three months ended Mar. 31, 2012 of $87 million or $0.75 reported diluted loss per share, compared with net income of $56 million reported in the comparable 2011 period or $0.46 reported diluted earnings per share.  The 2012 net loss was primarily driven by a one-time charge related to a first quarter 2012 accrual stemming from a 2010 litigation settlement with Impax Laboratories Inc. (Impax).  Additionally, adjusted net income for the three months ended March 31, 2012, was $106 million, down 12 percent, compared with $120 million in the same period in 2011.  Adjusted diluted earnings per share for first quarter 2012 were $0.87, down 13 percent from $1.00 reported in 2011.

    "I'm extremely proud of the response by the organization in resolving the challenging, but temporary, constraints to supplies of som
    '/>"/>

    SOURCE Endo
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

    Related medicine technology :

    1. Hospira Reports First-Quarter 2012 Results
    2. Luminex Corporation Reports First Quarter 2012 Results
    3. PAREXEL Reports Third Quarter Fiscal Year 2012 Financial Results
    4. CryoLife Reports Record Quarterly Revenues in First Quarter of 2012
    5. Mylan Reports Q1 2012 Adjusted Diluted EPS of $0.52, an 18% Increase Over Prior Year Quarter
    6. Varian Medical Systems Reports Results for Second Quarter of Fiscal Year 2012
    7. Kelyniam Global Inc. Reports Record Cranial Implant Revenues in the 1st Quarter of 2012
    8. Sigma-Aldrich (NASDAQ: SIAL) Reports Q1 2012 Diluted EPS of $0.96, With Diluted Adjusted EPS of $0.99. Sales Increase 5% for Q1 2012. Full Year 2012 Diluted Adjusted EPS Outlook of $3.90 to $4.05 Reaffirmed.
    9. Qmed, the Leading Global MedTech Industry Resource, Partners with Clarimed, to Provide the Medical Manufacturing and Healthcare Industry with FDA Reports on Adverse Events
    10. Cepheid Reports 2012 First Quarter Results
    11. Sotera Wireless Reports FDA Clearance of ViSi Mobile™ System
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/24/2014)... -- Echo Therapeutics, Inc. (NASDAQ: ECTE ... permeation, continuous glucose monitoring and associated technologies, today ... been appointed Chief Executive Officer effective December 22, ... of experience in the medical device, pharmaceutical and ... Vice President, Business Development, Otsuka Pharmaceuticals as well as ...
    (Date:12/24/2014)... MASON, Ohio , Dec. 23, 2014 /PRNewswire/ ... industry-leading treatment decision support to healthcare providers for ... that it has secured $30 million in equity ... Virginia C. Drosos , President and Chief ... increased clinical adoption and development of Assurex Health,s ...
    (Date:12/24/2014)... RALEIGH, N.C. , Dec. 23, 2014 /PRNewswire/ ... (NASDAQ: ENDP ) (TSX: ENL), and BioDelivery ... today that they have submitted a New Drug Application ... Food and Drug Administration (FDA).  Buprenorphine HCl Buccal Film ... enough to require daily, around-the-clock, long-term opioid treatment and ...
    Breaking Medicine Technology:Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 2Echo Therapeutics Announces Scott W. Hollander as President & Chief Executive Officer 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 2Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 3Assurex Health Secures $30 Million Financing Round to Continue Growth in Neuropsychiatric Pharmacogenomics 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 2Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 3Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 4Endo Pharmaceuticals and BioDelivery Sciences Announce NDA Submission for Buprenorphine HCl Buccal Film for the Management of Moderate to Severe Chronic Pain 5
    ... 2011 Kensey Nash Corporation (Nasdaq: KNSY ) ... (SBIR) grant from the National Institutes of Health (NIH). ... $1.9 million Phase II SBIR grant to further investigate the ... repair procedures.  The Company will develop and evaluate the ability ...
    ... Nov. 7, 2011 /PRNewswire-Asia-FirstCall/ -- Tianyin Pharmaceutical Inc. (NYSE ... specializes in patented biopharmaceutical medicine, modernized traditional Chinese medicine ... announced that the earnings conference call for the first ... will be held at 8:30 a.m. Eastern Time on ...
    Cached Medicine Technology:TPI to Host First Quarter Fiscal Year 2012 Earnings Conference Call on Monday, November 14, 2011 at 8:30 a.m. ET 2
    (Date:12/25/2014)... 2014 The report “TS-1 (Colorectal Cancer) ... the current treatment landscape, unmet needs, current pipeline and ... an anti-cancer drug which is typically used for treating ... used for treating gastric cancer and pancreatic cancer. TS-1 ... drug was first approved in 1999 in Japan for ...
    (Date:12/25/2014)... (PRWEB) December 25, 2014 The short film ... was created in honor of a true 9/11 hero, Welles ... film festivals including the 24 hours of Nuremberg International Short ... Bangladesh. , Actress, screenwriter and director Luciana Lagana ... this film together with her husband, Gregory Graham ...
    (Date:12/25/2014)... Recently, LunaDress.co.uk has updated its blog to provide professional shopping ... of the models at LunaDress.co.uk come with big discounts, up to ... veil can turn out to be a most exciting memory and ... always bring surprise to a wedding. On the updated fashion blog, ... veils for a big day . , Going out with friends ...
    (Date:12/25/2014)... HealthDay Reporter WEDNESDAY, Dec. ... on a "fountain of youth" drug that can delay the ... a new study suggests. Seniors received a significant boost ... a genetic signaling pathway linked to aging and immune function, ... The experimental medication, a version of the drug rapamycin, improved ...
    (Date:12/25/2014)... North Carolina (PRWEB) December 25, 2014 ... North Carolina Retirement Community, recently showed their generous ... girls of the Catawba County Parenting Network- Grandparents ... the 10 children gathered around the largest Christmas ... to open presents purchased by residents of the ...
    Breaking Medicine News(10 mins):Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:TS-1 Colorectal Cancer Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 2Health News:The True 9/11 Hero Story “Color of Honor” Premieres in Germany and Bangladesh: Luciana Lagana Plays the Mother of the Lead and Co-Produces with Blaise Dolcemaschio. 3Health News:LunaDress Provides Professional Tips On Shopping Wedding And Prom Dresses 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 2Health News:Researchers Take 'First Baby Step' Toward Anti-Aging Drug 3Health News:Retirement Community Residents Make Impact During Holiday Season 2
    ... Thousands of research studies have documented how the ... the cardiovascular system, particularly among people diagnosed with ... on this topic creates difficulty for many physicians ... recommendations related to these oils. In the March ...
    ... Intracranial hypertension left patients almost 5 times more likely ... News) -- Black Americans are more likely than other ... intracranial hypertension, or increased pressure in the brain, according ... School of Medicine in Atlanta reviewed the medical records ...
    ... a rare type of ovarian cancer, is less sensitive ... more common high-grade ovarian cancers, according to researchers from ... The findings were reported at the Society of Gynecologic ... retrospective study is the first to analyze how women ...
    ... March 10 Give an Hour, (http://www.giveanhour.org ), ... to returning Veterans and their loved ones,announces that ... network., In an effort to supplement the ... the military health care system, Give an Hour,s,services ...
    ... about climate change, energy security, and other concerns expressed ... USA launched From Electrons to Elections, a science and ... From Electrons to Elections is a non-partisan resource designed ... issues and provide them with the platforms of the ...
    ... be getting them, study says , , MONDAY, March 10 (HealthDay ... choices for kidney cancer more than clinical factors such as ... finds. , This means many patients who are candidates ... where only part of the kidney is removed, may not ...
    Cached Medicine News:Health News:Mayo Clinic proceedings highlights research about cardiovascular benefits of omega-3 fatty acids 2Health News:Brain Disease Causes More Vision Loss in Blacks 2Health News:Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers 2Health News:Recurrent low-grade carcinoma of the ovary less responsive to chemo than more common ovarian cancers 3Health News:1,000 Mental Health Professionals Join National Network to Provide Free Counseling to Returning Veterans and their Families 2Health News:Student Pugwash USA launches science policy election guide for young voters 2Health News:Surgeon's Preferences Dictate Choice of Kidney Cancer Surgery 2Health News:Surgeon's Preferences Dictate Choice of Kidney Cancer Surgery 3
    Instrument Cover for Vibratome....
    This is a perfect tool for retrieving free floating sections from the Vibratome bath....
    Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi...
    Specimen mounts are designed to allow for the rotation of the specimen in the Vibratome vice assembly for sectioning at different horizontal orientations....
    Medicine Products: